Consequently, inhibition of the JAK/STAT pathway by IL‐11/IL‐11RA disruption resulted in a significant reduction of oncogenic properties, reduced tumour growth of lung adenocarcinoma xenografts and decreased susceptibility to lung cancer in a GEMM model with IL‐11RA knockout in both tumour and normal cells. This evidence concerns the gene IL11 and lung cancer.